Overview

Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia

Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and efficacy of lefamulin, a pleuromutilin, for the treatment of adults with moderate to severe community-acquired bacterial pneumonia.
Phase:
Phase 3
Details
Lead Sponsor:
Nabriva Therapeutics AG
Treatments:
Anti-Bacterial Agents
Fluoroquinolones
Lefamulin
Linezolid
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination